ישראל - עברית - Ministry of Health

pharma shalom - fexofenadine hydrochloride - טבליות מצופות פילם - fexofenadine hydrochloride 120 mg - fexofenadine - fexofenadine - relief of symptoms associated with seasonal allergic rhinitis

ישראל - עברית - Ministry of Health

pharma shalom - fexofenadine hydrochloride - טבליות מצופות פילם - fexofenadine hydrochloride 180 mg - fexofenadine - fexofenadine - relief of symptoms associated with chronic idiopathic urticaria.

ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - fexofenadine hydrochloride - טבליות מצופות פילם - fexofenadine hydrochloride 120 mg - fexofenadine

ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - fexofenadine hydrochloride - טבליות מצופות פילם - fexofenadine hydrochloride 180 mg - fexofenadine

ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - fexofenadine hydrochloride - טבליות מצופות פילם - fexofenadine hydrochloride 180 mg - fexofenadine

ישראל - עברית - Ministry of Health

sanofi - aventis israel ltd - fexofenadine hydrochloride 180 mg - film coated tablets - fexofenadine - relief of symptoms associated with chronic idiopathic urticaria.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - fesoterodine fumarate - טבליות עם שחרור מושהה - fesoterodine fumarate 4 mg - fesoterodine - fesoterodine - treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur in patients with overactive bladder syndrome.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - fesoterodine fumarate - טבליות עם שחרור מושהה - fesoterodine fumarate 8 mg - fesoterodine - fesoterodine - treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur in patients with overactive bladder syndrome.

ישראל - עברית - Ministry of Health

inovamed ltd - bicalutamide - טבליות מצופות פילם - bicalutamide 150 mg - bicalutamide - bicalutamide - in patients with locally advanced prostate cancer (t3 - t4 any n m0 t1 -t2 n+ m0), bicalutamide 150 mg is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable

ישראל - עברית - Ministry of Health

novartis israel ltd - octreotide - תמיסה להזרקה\אינפוזיה - octreotide 0.1 mg/ml - octreotide - octreotide - prevention of complications following pancreatic surgery. symptomatic control and reduction of gh and igf-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy. sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas / zollinger-ellison syndrome usually in conjunction with proton pump inhibitors or h2- antagonist therapy - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas. sandostatin is not an antitumour therapy and is not curative in these patients.emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.